Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio


Follow This Show

If you liked this show, you should follow Pharma Talk Radio.

In this podcast, you will hear a presentation from Dr Robert Garmise, Bristol-Myers Squibb, and Dr Paul Reichert, Merck, from the 2022 PODD Conference regarding developing molecules in space to benefit subcutaneous drug delivery including case studies of work done in the International Space Station, the potential of crystalline suspensions and future opportunities.

To learn more about the PODD Conference, please visit PODDConference.com.


Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled